Mondobiotech
 |
Mondobiotech is a Swiss-based biotechnology company focused on developing human peptides as medicaments for patients affected by rare diseases.
History
Mondobiotech was founded in 2000 by Fabio Cavalli and Dorian Bevec.[1] In March 2012, Pharma Times reported that mondoBIOTECH was “financially troubled” and was in exclusive negotiations with Pierrel Research, the contact research division of the Italian company Pierrel.[2]
Research and development
Mondobiotech creates drugs for rare diseases.
Achievements
- Winner of the Swiss Life Sciences Prize 2005.
- Selected Technology Pioneer 2008 by The World Economic Forum.
Notes and references
- ^ "Archived copy". Archived from the original on 2012-07-20. Retrieved 2012-02-29.
{{cite web}}: Unknown parameter|deadurl=ignored (|url-status=suggested) (help)CS1 maint: archived copy as title (link) - ^ Mansell, Peter (6 March 2012). "Pierrel in negotiations for mondoBIOTECH merger". Pharma Times. Retrieved 9 March 2015.
See also
External links
